GLYCEROLYTE 57 SOLUTION
FRESENIUS KABI AG
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GLYCEROLYTE 57 SOLUTION discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GLYCEROLYTE 57 SOLUTION 57G 124.2MG 1.6G 51.7MG 30MG has been permanently discontinued (last updated June 18, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GLYCEROLYTE 57 SOLUTION not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00783668
Strength
57G 124.2MG 1.6G 51.7MG 30MG
Dosage Form
SOLUTION
Route
0-UNASSIGNED
Active Ingredient
GLYCERINE SODIUM PHOSPHATE DIBASIC SODIUM LACTATE SODIUM PHOSPHATE MONOBASIC POTASSIUM CHLORIDE
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other Products from FRESENIUS KABI AG
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.